https://www.selleckchem.com/pr....oducts/terephthalic-
8% (95% CI, 0.88%-4.81%). In the SEER database, the median age at diagnosis of uveal melanomas was 63 (range 3-99 years) with a male-to-female ratio of 1.011. In comparison, uveal melanoma cases with BAP1 germline pathogenic variants from the US population (n= 27) had a median age at diagnosis of 50.5 years (range 16-71). Quantification of the risk of developing uveal melanoma can enhance counseling regarding surveillance in patients with germline BAP1 pathogenic variant. Quantification of the risk of developing uveal melanoma